Wang J et al. [55] found that the combination of GSTM1 null and GSTP1 Val was significantly associated with an elevated lung adenocarcinoma risk (OR = 2.4, 95% CI: 1.1 to 5.1). Here, GSTP1 is linked to lung adenocarcinoma.